| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ZSTK474 | GDSC1000 | pan-cancer | AAC | -0.052 | 0.08 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | 0.06 | 0.08 |
| mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.09 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.09 |
| mRNA | GSK2126458 | GDSC1000 | pan-cancer | AAC | -0.053 | 0.09 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | 0.096 | 0.09 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.059 | 0.09 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | -0.052 | 0.09 |
| mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | -0.055 | 0.09 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.1 |